+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Monthly Mining Industry Deals Review - August 2018

  • PDF Icon

    Report

  • 30 Pages
  • November 2018
  • Region: Global
  • GlobalData
  • ID: 4720472
Monthly Mining Industry Deals Review - August 2018

Summary

The "Monthly Mining Industry Deals Review - August 2018", report is an essential source of data and trend analysis on M&A (mergers, acquisitions, and asset transactions), in the mining industry. The report provides detailed comparative monthly data on the number of deals and their value, sub-divided into deal types, by status, by region, and country. The report also highlights top buyers and sellers by region in addition to top announced and completed deals by value globally.

Scope
  • Analyze market trends for mining industry in the global landscape

  • Analysis of M&As in the mining industry by region, and by country for the month of August 2018

  • Information on the top deals that took place in the industry by region, by country, and by company

  • Geographies covered include - Americas, Europe, Asia-Pacific, and Middle East & Africa.


Reasons to Buy
  • Enhance your decision making capability in a more rapid and time sensitive manner

  • Monitor mining M&A activities to perform market analysis

  • Find out the major M&A deal performing regions/countries for investments in the industry

  • Evaluate type of companies divesting/acquiring in the market

  • Identify growth segments and opportunities in each region/country within the industry

  • Identify top deals makers in the mining industry.

Table of Contents

1 Table of Contents
1.1. List of Tables
1.2. List of Figures
2. Executive Summary3. Sector Highlights: August 20184. Asia-Pacific Mining M&A5. The Americas Mining M&A6. Europe, Middle East And Africa Mining M&A7. Top Mining M&A Deals in August 2018
8. Appendix
8.1. Abbreviations
8.2. Methodology
8.2.1. Coverage
8.2.2. Secondary Research
8.3. Contact Us
8.4. Disclaimer
List of Tables
Table 1: Number and Value of M&A Deals by Region - Global, September 2017 - August 2018
Table 2: Number and Value of M&A Deals by Status - Global, September 2017 - August 2018
Table 3: Number and Value of M&A Deals by Type - Global, September 2017 - August 2018
Table 4: Number and Value of M&A Deals by Type - APAC, September 2017 - August 2018
Table 5: Number and Value of M&A Deals by Status - APAC, September 2017 - August 2018
Table 6: Number and Value of M&A Deals by Type - Americas, September 2017 - August 2018
Table 7: Number and Value of M&A Deals by Status - Americas, September 2017 - August 2018
Table 8: Number and Value of M&A Deals by Type - EMEA, September 2017 - August 2018
Table 9: Number and Value of M&A Deals by Status - EMEA, September 2017 - August 2018
Table 10: Top 15 Mining M&A Deals Announced - Global, August 2018
Table 11: Top 15 Mining M&A Deals Completed - Global, August 2018
List of Figures
Figure 1: Number and Value of M&A Deals by Region - Global, September 2017 - August 2018
Figure 2: Number and Value of M&A Deals by Region - Global, August 2018
Figure 3: Number and Value of M&A Deals by Country - Global, August 2018
Figure 4: Number and Value of M&A Deals by Status - Global, September 2017 - August 2018
Figure 5: Number and Value of M&A Deals by Type - Global, September 2017 - August 2018
Figure 6: Number and Value of M&A Deals by Country - APAC, August 2018
Figure 7: Number and Value of M&A Deals by Type - APAC, September 2017 - August 2018
Figure 8: Number and Value of M&A Deals by Status - APAC, September 2017 - August 2018
Figure 9: Number and Value of M&A Deals by Status by Type - APAC, August 2018
Figure 10: M&A Deals Top Buyers - APAC, August 2018
Figure 11: M&A Deals Top Sellers - APAC, August 2018
Figure 12: Number and Value of M&A Deals by Country - Americas, August 2018
Figure 13: Number and Value of M&A Deals by Type - Americas, September 2017 - August 2018
Figure 14: Number and Value of M&A Deals by Status - Americas, September 2017 - August 2018
Figure 15: Number and Value of M&A Deals by Status by Type - Americas, August 2018
Figure 16: M&A Deals Top Buyers - Americas, August 2018
Figure 17: M&A Deals Top Sellers - Americas, August 2018
Figure 18: Number and Value of M&A Deals by Country - EMEA, August 2018
Figure 19: Number and Value of M&A Deals by Type - EMEA, September 2017 - August 2018
Figure 20: Number and Value of M&A Deals by Status - EMEA, September 2017 - August 2018
Figure 21: Number and Value of M&A Deals by Status by Type - EMEA, August 2018
Figure 22: M&A Deals Top Buyers - EMEA, August 2018
Figure 23: M&A Deals Top Sellers - EMEA, August 2018

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie

  • Accord Healthcare

  • Advanced Accelerator Applications

  • Aeterna Zentaris

  • Aetos Biologics

  • Alexion Pharmaceuticals

  • Allpack

  • AlphaMab

  • Amgen

  • APEIRON Biologics

  • Apotex

  • Aptevo Therapeutics

  • AstraZeneca

  • Baxter International

  • Bayer

  • Bayer Healthcare

  • Beijing Fogangren Bio-Pharm Tech

  • Biogen

  • BioMarin Pharmaceutical

  • BioReliance

  • Boehringer Ingelheim BioXcellence

  • Boehringer Ingelheim

  • Bristol-Myers Squibb

  • BTG

  • Catalent

  • Celgene

  • Celltrion

  • Chiesi Farmaceutici

  • Chugai Pharmaceutical Co

  • Clinuvel Pharmaceuticals

  • Coherus BioSciences

  • Cook Pharmica

  • CSL

  • Dompe Farmaceutici

  • Eli Lilly

  • Elusys Therapeutics

  • Emergent BioSolutions

  • Endo International

  • F. Hoffmann-La Roche

  • Ferring International Center

  • Finox Biotech

  • GE Healthcare

  • Gedeon Richter

  • Gene Techno Science

  • Genentech

  • Genor BioPharma

  • GlaxoSmithKline

  • Grunenthal Group

  • Horizon Pharma

  • IDT Biologika

  • Intas Pharmaceuticals

  • Ipsen

  • Ironwood Pharmaceuticals

  • Jazz Pharmaceuticals

  • Johnson & Johnson

  • KBI Biopharma

  • Kyowa Hakko Kirin

  • La Jolla Pharmaceutical Company

  • LG Chem

  • MabPlex International

  • MannKind Corp

  • Medac

  • Medice Arzneimittel Pütter & Co.

  • MedImmune

  • Merck & Co / MSD

  • Merck KGaA

  • Mustafa Nevzat Pharmaceuticals

  • Mylan

  • Novartis

  • Novartis International

  • Novelion Therapeutics

  • Novo Nordisk AS

  • Octapharma

  • Ono Pharmaceutical Co

  • Pall Corp

  • Patheon

  • PCI Pharma Services

  • Pfizer

  • Pharming Group

  • Polymun Scientific Immunbiologische Forschung

  • Portola Pharmaceuticals

  • Protalix BioTherapeutics

  • Regeneron Pharmaceuticals

  • Rentschler Biopharma

  • rEVO Biologics

  • Richter Gedeon

  • Richter-Helm Biologics & Co.

  • Samsung Bioepis

  • Samsung BioLogics

  • Sandoz

  • Sanofi

  • ScinoPharm Taiwan

  • Seattle Genetics

  • Serenity Pharmaceuticals

  • Servier

  • Shanghai Mab Venture Biopharm

  • ShangPharma Corporation

  • Shenzen Techdow Pharmaceutical Co.

  • Shire

  • Sicor Biotech

  • SK Chemicals

  • Spectrum Pharmaceuticals

  • Stada Arzneimittel

  • Sun Pharma Advanced Research Company

  • Swedish Orphan Biovitrum

  • Synergy Pharmaceuticals

  • Syngene International

  • TaiMed Biologics

  • Teva Pharmaceutical Industries

  • The Medicines Company

  • Theratechnologies

  • ThromboGenics NV

  • TOLMAR

  • UCB

  • Ultragenyx Pharmaceutical

  • United Therapeutics

  • Vetter Pharma-Fertigung

  • Walvax Biotechnology

  • Wockhardt Contract Manufacturing

  • WuXi AppTec

  • Wuxi Biologics